Cyanobacteria–probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis
Proceedings of the National Academy of Sciences · 24.12.2024 · 121 (52)
DOI: 10.1073/pnas.2403417121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.12.2024. Verfasst von Jiali Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, People's Republic of China. Hauptthemen laut MEDLINE: Colitis, Gastrointestinal Microbiome, Probiotics, Symbiosis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: | National Natural Science Foundation of China-Henan Joint Fund (-), 河南省人民政府 | National Natural Science Foundation of China-Henan Joint Fund.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is often associated with excessive inflammatory response and highly dysregulated gut microbiota. Traditional treatments utilize drugs to manage inflammation, potentially with probiotic therapy as an adjuvant. However, current standard practices often suffer from detrimental side effects, low bioavailability, and unsatisfactory therapeutic outcomes. Microbial complexes characterized by mutually beneficial symbiosis hold great promise for IBD therapy. Here, we aggregated Synechocystis sp. PCC6803 (Sp) with Bacillus subtilis (BS) by biomimetic mineralization to form cyanobacteria–probiotics symbionts (ASp@BS), which reshaped a healthy immune system and gut microbiota in a murine model of acute colitis. The symbionts exhibited excellent tolerance to the harsh environment of the gastrointestinal tract. Importantly, probiotics within the symbionts created a local anaerobic environment to activate the [NiFe]-hydrogenase enzyme of cyanobacteria, facilitating the production of hydrogen gas (H 2 ) to persistently scavenge elevated reactive oxygen species and alleviate inflammatory factors. The resulting reduced inflammation improves the viability of the probiotics to efficiently regulate the gut microbiota and reshape the intestinal barrier functions. Our research elucidates that ASp@BS leverages the synergistic interaction between Sp and BS to create a therapeutic platform that addresses multiple aspects of IBD, offering a promising and comprehensive solution for IBD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, People's Republic of China.
- Department of Neuroscience, Institute of Brain Science and Disease, Qingdao Medical College of Qingdao University, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao Uni…
- Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou 450001, People's Republic of China.
- State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou 450001, People's Republic of China.
ORCID-Profile: Wei Liu, Kaixiang Zhang, Zhi-Hao Wang, Jinjin Shi
Förderung
- | National Natural Science Foundation of China-Henan Joint Fund (-)
- 河南省人民政府 | National Natural Science Foundation of China-Henan Joint Fund
Zitieren
APA
Yang, J., Tan, S., Ge, S., Yang, M., Liu, H., Liu, W., Zhang, K., Zhang, Z., Wang, Z. H., Shi, J., & Liu, J. (2024). Cyanobacteria–probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis. Proceedings of the National Academy of Sciences, 121(52). https://doi.org/10.1073/pnas.2403417121
Vancouver
Yang J, Tan S, Ge S, Yang M, Liu H, Liu W, et al. Cyanobacteria–probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis. Proceedings of the National Academy of Sciences. 2024;121(52). doi:10.1073/pnas.2403417121
BibTeX
@article{Yang2024,
author = {Yang, Jiali and Tan, Shaochong and Ge, Shengchan and Yang, Mingzhu and Liu, Hua and Liu, Wei and Zhang, Kaixiang and Zhang, Zhenzhong and Wang, Zhi-Hao and Shi, Jinjin and Liu, Junjie},
title = {Cyanobacteria–probiotics symbionts for modulation of intestinal inflammation and microbiome dysregulation in colitis},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {52},
doi = {10.1073/pnas.2403417121}
}
EUVIMED